Skip to main content
OpenTrials
Completed

NCT Number: NCT07053930

Comparison of the Mean Duration of 3rd Stage of Labour Between Intraumbilical and Intravenous Oxytocin

There is always a debate for choosing the best method for management of the third stage of labour (TSL) in the general practice for reducing the duration of TSL. Although intravenous oxytocin is more extensively used in general practice for managing TSL than intraumbilical, it still needs to be properly investigated among local populations and in local settings.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Labor

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Sadiq Abbasi Hospital

Bahawalpur, Punjab Province, 63100, Pakistan

About this study

The findings of this study could identify the better route of oxytocin injection that could guide clinicians and health providers to opt for the better route in their routine practice for the management of TSL in order to reduce the morbidity and mortality of the patients, especially for developing countries like Pakistan, where most of the deliveries are conducted at peripheral or rural centers by a nurse, midwife, or a trained dai.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females aged 18-40 years
  • With spontaneous vaginal delivery
  • Singleton pregnancy
  • Gestational age >37 weeks
  • Parity l-5
  • Any gravidity

Exclusion criteria

  • Females with intrauterine fetal death
  • Malpresentation
  • Multiple pregnancy
  • Polyhydramnios
  • Premature rupture of membranes
  • Medical disorders and hypertensive disorders of pregnancy

Treatment and study plan

Intraumbilical oxytocin

Drug

Patients were given 10 U of intraumbilical oxytocin, diluted in 10 mL of normal saline.

Intravenous Oxytocin

Drug

Patients received 20 U of intravenous oxytocin diluted in 500 mL of normal saline.

Primary outcomes

  1. Duration of the third stage labour

    Time frame: 30 minutes

    The duration of the third stage labour was measured from the completed delivery of the newborn until the completed delivery of the placenta.

Sponsors and collaborators

Lead sponsor

RESnTEC, Institute of Research

Other

Registry information

Official study title

To Compare the Mean Duration of Third Stage of Labour Between Intraumbilical and Intravenous Oxytocin.

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 8, 2025
Registry last updated
Jul 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.